Stress ulcer prophylaxis of intravenous esomeprazole in Chinese seriously ill patients - SUP

Study identifier:D961OC00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Effect of intravenous esomeprazole versus cimetidine in prevention of Stress Ulcer Prophylaxis in Chinese seriously ill patients - a randomized, double-blind, parallel-group study

Medical condition

Stress Ulcer Prophylaxis

Phase

Phase 3

Healthy volunteers

No

Study drug

Esomeprazole, Cimetidine

Sex

All

Actual Enrollment

343

Study type

Interventional

Age

18 Years - 70 Years

Date

Study Start Date: 01 Jan 2014
Primary Completion Date: 01 Feb 2016
Study Completion Date: 01 Feb 2016

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Prevention

Verification:

Verified 01 Mar 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria